Literature DB >> 15236348

Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study.

F R Fusco1, A Martorana, C Giampà, Z De March, D Farini, V D'Angelo, G Sancesario, G Bernardi.   

Abstract

Several lines of evidence indicate that cannabinoids, among other functions, are involved in motor control. Although cannabinoid receptors (CB(1)) mRNA has been observed in medium-sized spiny neurons of the striatum, a description of the precise localization of CB(1) at a protein level among striatal cells is still lacking. Therefore, we performed immunohistochemical studies with light and confocal microscopy to identify neuronal subpopulations that express CB(1) and to assess the distribution of the receptor within these neurons. In our single label light microscopy study, CB(1) was observed in most medium-sized neurons of the caudate-putamen. However, CB(1) was also present in large-sized neurons scattered throughout the striatum. Our dual-label study showed that 89.3% of projection neurons in matrix contain CB(1), and that 56.4% of projection neurons in patch are labeled for CB(1). To investigate the presence of CB(1) among the different subclasses of striatal interneurons we performed a double-labeling study matching CB(1) and each of the striatal interneuron markers, namely, choline acetyl-transferase, parvalbumin, calretinin, and nitric oxide synthase. Our double-label study showed that most parvalbumin immunoreactive interneurons (86.5%), more than one-third (39.2%) of cholinergic interneurons, and about one-third (30.4%) of the NOS-positive neurons are labeled for CB(1). Calretinin-immunolabeled neurons were devoid of CB(1). Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236348     DOI: 10.1002/syn.20047

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  36 in total

Review 1.  Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output.

Authors:  Megan L Fitzgerald; Eli Shobin; Virginia M Pickel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-11       Impact factor: 5.067

2.  Selective breeding for high alcohol preference is associated with increased sensitivity to cannabinoid reward within the nucleus accumbens shell.

Authors:  Sheketha R Hauser; Simon N Katner; Robert A Waeiss; William A Truitt; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Pharmacol Biochem Behav       Date:  2020-07-23       Impact factor: 3.533

Review 3.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

4.  Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models.

Authors:  Eric A Horne; Jonathan Coy; Katie Swinney; Susan Fung; Allison E T Cherry; William R Marrs; Alipi V Naydenov; Yi Hsing Lin; Xiaocui Sun; C Dirk Keene; Eric Grouzmann; Paul Muchowski; Gillian P Bates; Ken Mackie; Nephi Stella
Journal:  Eur J Neurosci       Date:  2012-11-21       Impact factor: 3.386

5.  Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.

Authors:  Zuzana Justinová; Sergi Ferré; Godfrey H Redhi; Paola Mascia; Jessica Stroik; Davide Quarta; Sevil Yasar; Christa E Müller; Rafael Franco; Steven R Goldberg
Journal:  Addict Biol       Date:  2010-11-04       Impact factor: 4.280

6.  Decreased parvalbumin immunoreactivity in the cortex and striatum of mice lacking the CB1 receptor.

Authors:  Megan L Fitzgerald; Carl R Lupica; Virginia M Pickel
Journal:  Synapse       Date:  2011-03-28       Impact factor: 2.562

7.  Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.

Authors:  Cindy Casteels; Emili Martinez; Guy Bormans; Lluïsa Camon; Núria de Vera; Veerle Baekelandt; Anna M Planas; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-03       Impact factor: 9.236

8.  Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels.

Authors:  Zsuzsanna Sidló; Patricia H Reggio; Margaret E Rice
Journal:  Neurochem Int       Date:  2007-07-22       Impact factor: 3.921

9.  A potential function of endocannabinoids in the selection of a navigation strategy by rats.

Authors:  Pavel E Rueda-Orozco; Edgar Soria-Gomez; Corinne J Montes-Rodriguez; Marina Martínez-Vargas; Oscar Galicia; Luz Navarro; Oscar Prospero-García
Journal:  Psychopharmacology (Berl)       Date:  2007-09-06       Impact factor: 4.530

10.  Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.

Authors:  Skyla T Carney; Michael L Lloyd; Shanta E MacKinnon; Doshandra C Newton; Jenelle D Jones; Allyn C Howlett; Derek C Norford
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.